A pilot study published on Sept. 23 in JAMA Psychiatry reveals that reducing ultra-processed food intake by over 85% decreases depression symptoms in adults with high BMIs and metabolic disorders.
Dietary Shifts and Mental Health Improvements
The pilot trial tracked 20 participants who successfully cut their consumption of industrially manufactured foods by more than 85%. Following this reduction, participants exhibited moderate to large improvements across three distinct measures of depression. Anxiety scores among the cohort also registered modest gains. Ultra-processed items included in the study framework encompassed packaged snacks, fast food, and sugary beverages containing chemical preservatives, artificial colorings, flavor enhancers, and emulsifiers.
Corresponding author Nyasha Chagwedera, MD, PhD, assistant professor in the UCSF Department of Psychiatry and Behavioral Sciences, noted the behavioral hurdles of altering intake. “Reducing the amount of ultra-processed food in our diet can be challenging, because it’s highly palatable, cheap, and convenient,” Chagwedera stated. “Ultra-processed food triggers dopamine, the pleasure hormone, which promotes craving. Food companies work with scientists to find just the right amount of sugar, salt, and fat that make you want to eat more and more.”
Examining the Gut-Brain Connection
The participant pool averaged 44 years of age, with 70% identifying as female. Alongside depression, 14 individuals presented with anxiety. Every participant carried a high body mass index (BMI) alongside at least one metabolic disorder, such as hypertension, diabetes, or elevated low-density lipoprotein (LDL) cholesterol. Researchers divided participants into two distinct tracks: one group maintained standard dietary habits for four weeks, while the other transitioned to a low ultra-processed diet using groceries they selected and purchased independently under research supervision. After four weeks, the groups crossed over.
Chagwedera, who established the UCSF Metabolic and Mental Health Program, pointed to physical changes in the digestive tract as a potential mechanism linking processed diets to mood disorders. According to this model, additives and processing methods may degrade the protective lining of the gut. “This gut damage can create low-grade, chronic inflammation throughout the body that either directly causes depression or makes people more vulnerable to it,” Chagwedera explained. “In other words, junky processing may harm your gut in ways that ripple up to your brain.”
Phase 2 Trial Expansion Timeline
Because the pilot trial involved a limited sample size of 20 individuals, investigators emphasize that the findings remain preliminary. Senior author Andrew Krystal, MD, the Ray and Dagmar Dolby Distinguished Professor in the UCSF departments of Psychiatry and Behavioral Sciences and Neurology, confirmed that the initial effort “successfully established the viability of carrying out this research in a larger-scale trial.”
Building on these results, UCSF researchers have scheduled enrollment for a expanded phase 2 clinical trial to begin in 2028. Funding for the initial work was provided by the National Center for Advancing Translational Sciences and the National Institutes of Health through UCSF-CTSI Grant Number UL1 TR001872, alongside NHLBI grant R38AG070171, NIMH grant R38AG070171, and the UCSF Weill Institute of Neurosciences.
Keep reading